Metformin Hydrochloride; Pioglitazone Hydrochloride Patent Expiration

Metformin Hydrochloride; Pioglitazone Hydrochloride is used for improving glycemic control in patients with type 2 diabetes already on a combination of pioglitazone and metformin or a thiazolidinedione (TZD) and metformin. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Actoplus Met on Aug 29, 2005. Another drug containing Metformin Hydrochloride; Pioglitazone Hydrochloride is Actoplus Met Xr. 7 different companies have introduced drugs containing Metformin Hydrochloride; Pioglitazone Hydrochloride.


Metformin Hydrochloride; Pioglitazone Hydrochloride Patents

Given below is the list of patents protecting Metformin Hydrochloride; Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Actoplus Met US5965584 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met US6166042 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met US6166043 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met US6172090 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met US9101660 Solid preparation Jan 22, 2027 Takeda Pharms Usa
Actoplus Met US9320714 Tablet Feb 03, 2029 Takeda Pharms Usa
Actoplus Met Xr US5965584 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US6099859 Controlled release oral tablet having a unitary core Mar 20, 2018

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US6166042 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US6166043 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US6172090 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US6495162 Controlled release oral tablet having a unitary core Mar 20, 2018

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US6790459 Methods for treating diabetes via administration of controlled release metformin Mar 17, 2021

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US6866866 Controlled release metformin compositions Mar 17, 2021

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US7785627 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Jul 31, 2026 Takeda Pharms Usa
Actoplus Met Xr US7919116 Controlled release metformin formulations Mar 20, 2018

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US7959946 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Jul 31, 2026 Takeda Pharms Usa
Actoplus Met Xr US8470368 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Sep 19, 2023

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US8475841 Controlled release metformin formulations Mar 20, 2018

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US8668931 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Sep 19, 2023

(Expired)

Takeda Pharms Usa
Actoplus Met Xr US9060941 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative Sep 19, 2023

(Expired)

Takeda Pharms Usa


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Metformin Hydrochloride; Pioglitazone Hydrochloride Generics

Several generic applications have been filed for Metformin Hydrochloride; Pioglitazone Hydrochloride. The first generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride was by Mylan Pharmaceuticals Inc and was approved on Feb 25, 2011. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Nov 5, 2015.

Given below is the list of companies who have filed for Metformin Hydrochloride; Pioglitazone Hydrochloride generic.


1. TORRENT PHARMS LTD

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
850MG; EQ 15MG BASE tablet Discontinued ORAL N/A Feb 13, 2013
500MG; EQ 15MG BASE tablet Discontinued ORAL N/A Feb 13, 2013


2. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
850MG; EQ 15MG BASE tablet Discontinued ORAL N/A Feb 25, 2011
500MG; EQ 15MG BASE tablet Discontinued ORAL N/A Feb 25, 2011


3. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG; EQ 15MG BASE tablet Prescription ORAL AB Feb 13, 2013
850MG; EQ 15MG BASE tablet Prescription ORAL AB Feb 13, 2013


4. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG; EQ 15MG BASE tablet Prescription ORAL AB Nov 5, 2015
850MG; EQ 15MG BASE tablet Prescription ORAL AB Nov 5, 2015


5. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
850MG; EQ 15MG BASE tablet Prescription ORAL AB Mar 10, 2014
500MG; EQ 15MG BASE tablet Prescription ORAL AB Mar 10, 2014


6. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG; EQ 15MG BASE tablet Discontinued ORAL N/A Apr 16, 2013
850MG; EQ 15MG BASE tablet Discontinued ORAL N/A Apr 16, 2013